Enjoy complimentary customisation on priority with our Enterprise License!
The immunohematology market size is estimated to grow by USD 1.27 billion at a CAGR of 9.06% between 2022 and 2027.
There is an increasing shift by end-users to automated immunohematology analyzers in the global market. Several manufacturers in the market are increasingly focusing on developing automated and semi-automated immunohematology analyzers that can minimize the requirement for manual methods and help reduce human errors. Additionally, there is an increasing demand for semi- and fully-automated immunohematology analyzers in the market due to the growing need for blood transfusions for different surgical procedures. The blood banks and hospitals constitute a huge quantity of blood units, which need regular screening. Hence, Tier 1 companies such as Immucor, Grifols, and Ortho Clinical Diagnostics have launched automated immunology analyzers that can meet the demand of different end-users as well as minimize staff and human errors. Hence, such factors are expected to positively impact the market growth.
To learn more about this report, Request Free Sample
This report extensively covers immunohematology market segmentation by product (analyzers and systems and reagents) and geography (North America, Europe, Asia, and ROW).
The analyzers and systems segment is estimated to witness significant growth during the forecast period. Factors such as the high demand potential of automated analyzers in blood banks and next-generation immunohematology analyzers with better throughput will significantly influence the growth of the immunohematology analyzer and system market. Several market players in the market are focusing on developing next-generation immunohematology analyzers with improved speed, performance, and automation.
Get a glance at the market contribution of various segments View a PDF Sample
The analyzers and systems segment was the largest segment and was valued at USD 1.20 billion in 2017. For instance, Immucor developed NEO that targets Tier 1 hospitals and reference laboratories. The main advantage of this analyzer is that it can process 224 test samples at the same time and offer a broad test menu for the recipient and donor. There is a growing prominence for automated immunohematology analyzers due to their high potential for manual blood bank testing replacement. As a result, the analyzer is being considered an ideal option as well as a possible replacement for traditionally performed manual methods in blood bank testing. Hence, such factors are expected to fuel the growth of this segment which in turn will drive the market growth during the forecast period.
One of the largest end-user segments for the market is the hospitals, including multispecialty hospitals and hospital groups, which work under government sponsorship or through private entities. Some of these hospitals can accommodate more than 500 individual patients within their locality. These hospitals provide a large number of inpatient and outpatient services such that diagnosis and monitoring of most surgical events are conducted in outpatient settings. Hence, the demand for immunohematology analyzers, instruments, and reagents is fuelled by the increased number of hospital admissions for surgical care. Thus such factors are expected to fuel the growth of this segment which in turn will drive the market growth during the forecast period.
For more insights about the market share of various regions View PDF Sample now!
North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. One of the main reasons for the market in North America is factors such as the rising number of hospital-acquired infections (HAIs) in individuals. Additionally, there is an increasing need for blood in surgical procedures including general surgery or organ transplantation. One of the main dominant markets in North America in the market is the US. As per the CDC, in the US, 3.2% of patients suffer from at least one hospital-acquired infection (HAI) in a day. Some of the conditions in HAIs include pneumonia, bloodstream-related infections, and other types of infections. There are several government initiatives to spread awareness of the Affordable Care Act (ACT) for medical safety has significantly contributed to the market growth. Hence, such factors are expected to drive the market in the region during the forecast period.
Buy Now Full Report and Discover More
The Immunohematology Market is experiencing robust growth due to rising demand for blood donations and immunohematology testing. As blood donations serve as the primary source for transfusion, ensuring compatibility through immunohematology testing is essential for patient safety. This market is witnessing significant traction driven by advancements in technology, including automated immunohematology instruments, which enhance accuracy and efficiency in testing processes. Key players like Ortho Clinical Diagnostics and Grifols are offering a diverse range of products and solutions, addressing the increasing prevalence of blood-related disorders and the need for blood transfusions. However, challenges persist, such as the high cost of products, particularly in developing regions. Despite this, the market is forecasted to grow substantially, fueled by the continuous emphasis on blood transfusion safety and the growing adoption of immunohematology testing worldwide. There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
One of the key factors driving the market growth is the growing demand for blood banks and their potential to increase sales. There is an increasing demand for blood banks across the world. These blood banks collect and store blood from donors by utilizing a bloodmobile or the donors can visit the centers for blood donation. It is then transfused to many screening tests, including screening for infectious disease and blood typing, and serological tests for blood plasma.
Moreover, one of the important aspects in the market is cord blood banking. Once the cord blood is donated, the blood bank preserves it after subjecting it to several tests, including immunohematology. Hence, the growing demand for blood components and cord blood for storage in the blood bank and transfusion is expected to drive the market during the forecast period.
A key factor shaping the market growth is the paradigm shift toward molecular immunohematology. One of the main methods that help in the identification of the molecular and genetic basis of any antigen is molecular analysis. The main advantage of this method is that it helps clinicians understand the molecular basis of blood group antigens and blood typing.
Additionally, there is a growing popularity for this method as it is the ideal method to understand the cross-matching of donor and recipient blood. Furthermore, there is an increasing adoption of molecular immunohematology along with serological typing and HLA typing across many blood banks and hospitals. Hence, such factors are expected to drive the market during the forecast period.
High maintenance costs and low reimbursement for blood components are one of the key challenges hindering market growth. There is an increasing cost burden on blood banks due to the increasing cost of the maintenance of blood components associated with labor cost, reagents and disposables cost, and storage. For instance, the average cost of cord blood handling is around USD 1,500 per year.
As a result, several public and private blood banks enforce a charge for registration and ask for an annual charge from donors. Furthermore, there is low adoption of these products due to low reimbursements. For example, if the cost of the RBC unit is around USD150-USD165, the reimbursed amount comprises only USD75-USD80. Hence, such factors are expected to hinder the market during the forecast period.
Buy Now Full Report and Discover More
The market growth and forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market research and growth report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The market growth analysis report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Becton Dickinson and Co: The company offers several immunohematology products, such as BD Vacutainer serum tubes and BD Vacutainer EDTA tubes among others.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market is witnessing growth driven by factors like increased blood donations, rising demand for immunohematology testing, and a surge in elective surgical procedures. Technological advancements and the development of new products are also contributing to market expansion. Blood-related disorders, such as hemophilia, sickle cell disease, and blood cancer, are fueling the demand for hematological testing. Furthermore, the high burden of leukemia and other blood disorders necessitates advanced hematology analyzers for accurate results. Despite challenges like the high cost of products and shortage of skilled personnel, rising adoption rates of automated immunohematology instruments and increasing government initiatives are expected to drive market progression. With continuous research and development efforts, the Immunohematology Market is poised for further growth, catering to the increasing prevalence of hematological disorders globally.
The market forecasting report covers market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
Immunohematology Market Scope |
|
Market Report Coverage |
Details |
Page number |
160 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 9.06% |
Market growth 2023-2027 |
USD 1.27 billion |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
6.44 |
Regional analysis |
North America, Europe, Asia, and Rest of the World (ROW) |
Performing market contribution |
North America at 37% |
Key countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Becton Dickinson and Co., Biomed Global, Bio Rad Laboratories Inc., biosurfit SA, Cardinal Health Inc., Danaher Corp., DIAGAST SAS, Grifols SA, Hemo bioscience Inc., HUMAN Gesellschaft fur Biochemica und Diagnostica mbH, Institut de Biotechnologies Jacques Boy, MAK SYSTEM S.A., Merck KGaA, Mesa Laboratories Inc., Quotient Ltd., Siemens AG, Thermo Fisher Scientific Inc., Tulip Diagnostics Pvt. Ltd., Werfenlife SA, and Calibre Scientific Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
View Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.